Publication | Closed Access

Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and Older

Breast OncologyCost-effectiveness AnalysisMedicineBrachytherapyBreast CancerBreast SurgeryOncologyRadiation OncologyWomen Aged 65RadiologyHealth Sciences